| 1 |
Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia. Haematologica. 2023 Jan 1;108(1):61-68.
|
| 2 |
Bronchiolitis obliterans syndrome is associated with increased senescent lymphocytes in the small airways. J Heart Lung Transplant. 2021 Feb;40(2):108-119.
|
| 3 |
Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series. Semin Arthritis Rheum. 2020 Oct;50(5):1109-1113.
|
| 4 |
Cyclosporin A protects JEG-3 cells against oxidative stress-induced apoptosis by inhibiting the p53 and JNK/p38 signaling pathways. Reprod Biol Endocrinol. 2020 Oct 12;18(1):100.
|
| 5 |
Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study. Front Immunol. 2023 Mar 8;14:1062919.
|
| 6 |
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Haematol. 2024 Feb;11(2):e127-e135.
|
| 7 |
Pustular psoriasis. Cutis. 1993 Jan;51(1):29-32.
|
| 8 |
Cyclosporin A (CyA) in primary Sj?gren's syndrome: a double blind study. Ann Rheum Dis. 1986 Sep;45(9):732-5.
|
| 9 |
Why Choose Cyclosporin A as First-line Therapy in COVID-19 Pneumonia. Reumatol Clin. 2020 Apr 16;S1699-258X(20)30044-9.
|
| 10 |
Anti-inflammatory therapy of dry eye. Ocul Surf. 2003 Jan;1(1):31-6.
|
| 11 |
Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
|
| 12 |
ClinicalTrials.gov (NCT03083782) Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
|
| 13 |
ClinicalTrials.gov (NCT00741338) Immune Tolerance Study With Aldurazyme (Laronidase)
|
| 14 |
ClinicalTrials.gov (NCT01193283) Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
|
| 15 |
ClinicalTrials.gov (NCT00303667) Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
|
| 16 |
ClinicalTrials.gov (NCT00133887) TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients
|
| 17 |
ClinicalTrials.gov (NCT00005113) A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
|
| 18 |
ClinicalTrials.gov (NCT01426334) Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate
|
| 19 |
ClinicalTrials.gov (NCT00983931) Drug-Drug Interaction Study Between Colchicine and Cyclosporine
|
| 20 |
ClinicalTrials.gov (NCT00002832) Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
|
| 21 |
ClinicalTrials.gov (NCT00514514) Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen
|
| 22 |
ClinicalTrials.gov (NCT00420537) Shift to Everolimus (RAD) Kidney Sparing Study
|
| 23 |
ClinicalTrials.gov (NCT00653276) MD Ezetimibe Cyclosporine Interaction (0653-057)
|
| 24 |
ClinicalTrials.gov (NCT03095547) Drug/Drug Interactions With F901318
|
| 25 |
ClinicalTrials.gov (NCT04597762) Effect of Ciclosporin Eyedrops on Sjgren Syndrome
|
| 26 |
ClinicalTrials.gov (NCT00002759) Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
|
| 27 |
ClinicalTrials.gov (NCT00840827) Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes
|
| 28 |
ClinicalTrials.gov (NCT01788501) Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease
|
| 29 |
ClinicalTrials.gov (NCT00001880) Stem Cell Transplantation for Metastatic Solid Tumors
|
| 30 |
ClinicalTrials.gov (NCT00005799) Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
|
| 31 |
ClinicalTrials.gov (NCT00014235) Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
|
| 32 |
ClinicalTrials.gov (NCT00008450) Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
|
| 33 |
ClinicalTrials.gov (NCT00008177) Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
|
| 34 |
ClinicalTrials.gov (NCT00005851) Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer
|
| 35 |
ClinicalTrials.gov (NCT03791827) Multicenter Registry of Pediatric Lupus Nephritis in China
|
| 36 |
ClinicalTrials.gov (NCT01038167) A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults
|
| 37 |
ClinicalTrials.gov (NCT00578643) Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease
|
| 38 |
ClinicalTrials.gov (NCT00378534) Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
|
| 39 |
ClinicalTrials.gov (NCT01789255) Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
|
| 40 |
ClinicalTrials.gov (NCT01659606) Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
|
| 41 |
ClinicalTrials.gov (NCT00040846) Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies
|
| 42 |
ClinicalTrials.gov (NCT02416388) Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR
|
| 43 |
ClinicalTrials.gov (NCT00087581) Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
|
| 44 |
ClinicalTrials.gov (NCT00118742) Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
|
|
|
|
|
|
|
